SCHEMBL5111346

SCHEMBL5111346

COc1ccc2c(O)c(-c3cc4c(=O)oc5cc(OC)ccc5c4o3)c(=O)oc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 3/20 0.57
KDM4E B2RXH2 7/20 0.55
ALDH1A1 P00352 7/20 0.55
MAPT P10636 6/20 0.55
NPC1 O15118 3/20 0.55
POLB P06746 2/20 0.55
RAB9A P51151 2/20 0.55
STAT1 P42224 1/20 0.55
LMNA P02545 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MAOB P27338 3/20 0.50
HPGD P15428 4/20 0.47
HSD17B10 Q99714 4/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
TP53 P04637 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5115686 0.88 NQO1 (0.57) NQO1KDM4EALDH1A1MAPTNPC1
SCHEMBL5115329 0.83 MAOB (0.44) NQO1KDM4EALDH1A1MAPTNPC1
SCHEMBL5111826 0.83 NOX4 (0.57) NQO1KDM4EALDH1A1MAPTNPC1
SCHEMBL5120928 0.81 MAOA (0.46) NQO1KDM4EALDH1A1MAPTPOLB
SCHEMBL5426832 0.80 MAOB (0.75) NQO1KDM4EALDH1A1MAPTNPC1
SCHEMBL5119152 0.80 NOX4 (0.40) NQO1KDM4EALDH1A1MAPTPOLB
SCHEMBL28665964 0.80 NQO1 (0.57) NQO1KDM4EALDH1A1MAPTNPC1
SCHEMBL5111292 0.79 KDM4E (0.50) NQO1KDM4EALDH1A1MAPTLMNA
SCHEMBL5141444 0.78 MAOB (0.71) NQO1KDM4EALDH1A1MAPTNPC1
SCHEMBL6276172 0.78 NQO1 (0.73) NQO1KDM4EALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US claimed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US claimed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S NQO1 60/4885KDM4E 3765/4885ALDH1A1 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.